Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Canine Adenovirus Serotype 1 Early E3 13.3 kDa Protein

Cat. No.VG2C63

Product TypeVeterinary Antigens

Size

Product Overview

BioVenic's Recombinant Canine Adenovirus Serotype 1 Early E3 13.3 kDa Protein is a recombinant protein expressed from Yeast. Its predicted molecular weight is 13.4 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Virus
Expression System Yeast
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 13.4 kDa
Physical State Lyophilized
Formulation Tris/PBS-based buffer, 5%-50% glycerol

Target Information

The canine adenovirus serotype 1 Early E3 13.3 kDa Protein is an early viral protein involved in modulating the host immune response. It helps the virus evade host defenses by downregulating MHC-I expression on the cell surface, thus preventing recognition by cytotoxic T cells. In veterinary medicine, this protein is important for understanding viral pathogenesis and immune evasion mechanisms. Its role in immune modulation makes it a potential target for antiviral therapies and vaccine development. Additionally, recombinant forms of this protein are used in research to develop diagnostic tools and study virus-host interactions.

Protein Canine Adenovirus Serotype 1 Early E3 13.3 kDa Protein
Protein Synonym Early E3 13.3 kDa protein
UniProt ID P68958

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket